Ascentage Pharma raises $126m in first biotech IPO of 2025
China-based biotech Ascentage Pharma has raised $126m in a US initial public offering (IPO), marking the first biotech IPO of…
News
Purdue and Sackler family agree to $7.4bn national opioid settlement
FDA approves drug application for Lupin’s heart failure therapy
Stealth faces another hurdle as FDA delays decision on Barth syndrome drug
Emcure Pharmaceuticals opens new R&D centre in Gujarat, India
AbbVie and Neomorph link on oncology/immunology glue degraders
Pharmaceutical Technology Excellence Awards 2024 – Winners Announced!
Biogen’s higher dose Spinraza under review by US and EU regulators
